Two inexpensive classes of drugs available in generic form each reduce the recurrence of breast cancer in post-menopausal women as well as death rates from the disease, a pair of studies reported Friday.
Taking the medications together may further boost anti-cancer benefits and help cancel out undesirable side-effects of one of the drugs, according to the research published in medical journal The Lancet.
The first "meta-study" pulling together data from nine trials covering 30,000 post-menopausal women found endocrine treatments based on a class of drugs called aromatase inhibitors yield higher survival rates after five years compared to standard endocrine therapy with tamoxifen.
The likelihood of cancer recurring was cut by about a third and the risk of dying by about 15 percent in the decade after treatment started. Compared to no treatment at all, the danger of dying from breast cancer fell by 40 percent, the study found.
Most women have already passed through menopause when breast cancer strikes. Even after surgery has removed all detectable traces, tiny amounts of the body's own hormones can cause cancer cells to grow.
Endocrine therapies are designed to impede these hormones from stimulating the disease, and so help protect against relapse.
"But aromatase inhibitor treatment is not free of side-effects and it's important to ensure that women" who suffer them are "supported", said the study's lead author, Mitch Dowsett of The Institute of Cancer Research in London.
The second meta-study, which scanned the results of 26 trials involving another 20,000 women, showed that another class of drugs called bisphosphonates -- usually taken to treat osteoporosis, a bone-weakening condition that becomes more common with age -- also significantly boosted survival when taken for at least two years.
When breast cancer spreads, bone is its favoured destination. Tumour cells released from the primary breast cancer can remain dormant in bones for years before moving to other parts of the body.
Bisphosphonates make the bones a less hospitable environment for the cancer cells and so reduce the risk of cancer recurring. The beneficial effect were found to be far more pronounced in post-menopausal women, regardless of the treatment duration, the size of the tumour or whether the cancer had spread to lymph nodes.
The therapy did not, however, reduce the risk of new cancers developing in the opposite breast.
"These simple, well-tolerated treatments should now be considered for routine use" in women with natural or medically induced menopause, lead author Robert Coleman from the University of Sheffield said in a statement.
Some two-thirds of all women with breast cancer are post-menopausal with hormone-sensitive tumours, so could potentially benefit from both drugs, the researchers conclude.
"The drugs are complementary," noted Oxford University's Richard Gray, lead statistician for the studies. "The main side effect of aromatase inhibitors is an increase in bone loss and fractures, while bisphosphonates reduce bone loss."
AFP RELAXNEWS
Fri Jul 24 2015
A study found that taking the medications together may further boost anti-cancer benefits.
Penyanyi veteran Hail Amir meninggal dunia
Penyanyi veteran, Datuk Hail Amir, 76 dilaporkan meninggal dunia di Hospital Kuala Lumpur pada jam 3.40 petang, Isnin.
Agong tiba di Singapura bagi lawatan negara
Yang di-Pertuan Agong Sultan Ibrahim dan Raja Permaisuri Agong Raja Zarith Sofiah berangkat tiba di Singapura pada Isnin bagi mengadakan Lawatan Negara selama dua hari ke republik berkenaan.
Lawatan Negara itu adalah yang pertama sejak Seri Paduka Baginda menaiki takhta pada 31 Januari lalu dan ia merupakan jemputan Presiden Singapura Tharman Shanmugaratnam.
Lawatan Negara itu adalah yang pertama sejak Seri Paduka Baginda menaiki takhta pada 31 Januari lalu dan ia merupakan jemputan Presiden Singapura Tharman Shanmugaratnam.
Malaysia seru kukuhkan perpaduan negara anggota OIC untuk hadapi cabaran dalam Dunia Islam
Malaysia menyeru supaya perpaduan dalam kalangan negara anggota Pertubuhan Kerjasama Islam (OIC) diperkukuh bagi menghadapi cabaran yang dihadapi Dunia Islam.
Kes tembak Pasir Mas: Empat individu selesai beri keterangan
Polis selesai mengambil keterangan empat individu berhubung kes tembakan di Kampung Alor Pinggan di Gelang Mas, Pasir Mas, Ahad lepas.
AWANI Borneo [06/05/2024] – Tiga lemas | MA63 | PRN Sabah
Laporan berita padat dan ringkas dari Borneo bersama Assim Hassan
#AWANIBorneo 6 Mei 2024
- Operasi SAr tamat, korban tragedi kepala air Lahad Datu kekal tiga mangsa
- Teruskan kerjasama dengan kerajaan pusat, pastikan tuntutan
MA63 tidak terhenti - kata Wan Junaidi
- Armizan sahkan tiada rundingan dengan pareti lain, GRS perkukuh kerjasama dengan PH plus
#AWANInews
#AWANIBorneo 6 Mei 2024
- Operasi SAr tamat, korban tragedi kepala air Lahad Datu kekal tiga mangsa
- Teruskan kerjasama dengan kerajaan pusat, pastikan tuntutan
MA63 tidak terhenti - kata Wan Junaidi
- Armizan sahkan tiada rundingan dengan pareti lain, GRS perkukuh kerjasama dengan PH plus
#AWANInews
'Hail Amir peramah, senyuman tak lekang di bibir' - DJ Dave
Allahyarham Datuk Hail Amir semasa hayatnya merupakan seorang yang peramah, tidak pernah burukkan orang dan sentiasa melemparkan senyuman.
Tiada perjanjian dengan kerajaan untuk gugurkan saman - Bekas Pengarah SRC
Bekas Pengarah SRC Shahrol Azral Ibrahim Halmi tidak mempunyai resolusi dengan kerajaan untuk menggugurkan saman sivil AS$1.18 bilion terhadapnya.
PM Anwar gesa respons bersama secara global semasa dunia berdepan landskap perpecahan
Datuk Seri Anwar Ibrahim menyeru tindak balas bersepadu secara global ditampilkan semasa dunia berhadapan dengan landskap global yang semakin berpecah-belah.
Tiada perbincangan dengan parti lain, GRS perkukuh kerjasama dengan PH plus
Timbalan Setiausaha Agung GRS Datuk Armizan Ali mengesahkan gabungan itu tiada berbincang engan parti lain bagi menghadapi PRN17 selain kerangka sedia ada iaitu bersama GRS plus.
Kemajuan projek LRA Kopogon lebih pantas daripada jadual
Ahli Parlimen Papar Datuk Armizan Mohd Ali berkata pihaknya akan berbincang mengenai kaedah bagi mempercepatkan projek LRA Kopogon agar dapat beroperasi secepat mungkin khususnya pada bahagian muka sauk dan loji rawatan.